DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.075
EU - Europa 6.451
AS - Asia 4.702
SA - Sud America 647
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 40
Totale 24.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.688
CN - Cina 2.084
RU - Federazione Russa 1.541
IT - Italia 1.374
SG - Singapore 1.306
DE - Germania 911
PL - Polonia 693
BR - Brasile 544
HK - Hong Kong 436
UA - Ucraina 360
GB - Regno Unito 323
CA - Canada 321
SE - Svezia 315
FI - Finlandia 272
FR - Francia 207
VN - Vietnam 173
TR - Turchia 164
KR - Corea 150
IE - Irlanda 109
IN - India 101
CZ - Repubblica Ceca 81
JP - Giappone 67
BE - Belgio 58
MX - Messico 52
NL - Olanda 47
AR - Argentina 40
EU - Europa 38
AU - Australia 37
PK - Pakistan 37
ZA - Sudafrica 37
ES - Italia 34
BD - Bangladesh 30
IR - Iran 26
EG - Egitto 22
AT - Austria 21
IQ - Iraq 20
EC - Ecuador 16
ID - Indonesia 16
LT - Lituania 14
UY - Uruguay 14
PT - Portogallo 13
HR - Croazia 12
PE - Perù 12
MY - Malesia 11
RO - Romania 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
HU - Ungheria 9
BY - Bielorussia 8
CO - Colombia 8
GR - Grecia 8
AZ - Azerbaigian 6
KE - Kenya 6
KG - Kirghizistan 6
PH - Filippine 6
VE - Venezuela 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CH - Svizzera 5
DK - Danimarca 5
LV - Lettonia 5
RS - Serbia 5
TW - Taiwan 5
UZ - Uzbekistan 5
CL - Cile 4
IL - Israele 4
NP - Nepal 4
AL - Albania 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
KH - Cambogia 3
LK - Sri Lanka 3
MA - Marocco 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
GE - Georgia 2
GH - Ghana 2
IS - Islanda 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
TN - Tunisia 2
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
Totale 24.035
Salva come PNG Salva come JPEG
Città #
Dallas 1.305
Fairfield 925
Ashburn 891
Jacksonville 864
Woodbridge 819
Chandler 602
Singapore 567
Warsaw 563
Houston 520
Ann Arbor 517
Wilmington 458
Boardman 425
Hong Kong 421
Seattle 369
Beijing 357
Camerino 351
Cambridge 293
Nanjing 275
Toronto 228
Dearborn 203
Los Angeles 196
New York 191
Seoul 144
San Mateo 140
Tongling 140
Lawrence 130
Princeton 129
Helsinki 127
The Dalles 126
Istanbul 122
Kraków 113
Munich 111
Dublin 110
Columbus 107
Nanchang 103
Ogden 96
Düsseldorf 93
Moscow 93
London 88
Buffalo 86
Milan 82
Shanghai 74
Shenyang 67
Guangzhou 62
Jiaxing 57
Kunming 57
Brno 56
São Paulo 56
Chicago 52
Ho Chi Minh City 52
Tokyo 52
Brussels 51
Lachine 50
Jinan 48
Tianjin 48
Turku 47
Santa Clara 46
San Diego 45
Changsha 39
Hebei 39
Bremen 38
Centro 36
Rome 36
Philadelphia 34
Hanoi 33
Frankfurt am Main 32
Phoenix 32
Zhengzhou 31
Dong Ket 29
Redondo Beach 29
Brooklyn 28
Redwood City 27
Hangzhou 26
Wuhan 26
Chennai 25
Denver 25
Stockholm 25
Venezia 25
Ningbo 24
Johannesburg 23
Nuremberg 23
Hefei 22
Mexico City 22
Poplar 22
Leawood 21
Manchester 21
Montreal 21
Perugia 21
Council Bluffs 20
Falls Church 19
Monmouth Junction 19
Atlanta 18
Olomouc 18
Taizhou 18
Boston 17
Orange 17
Pesaro 17
Washington 17
Nantong 16
Nürnberg 16
Totale 15.447
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 587
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 582
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 525
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 517
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 492
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 323
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 319
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 308
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 305
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 304
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 284
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 284
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 283
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 282
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 275
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 268
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 262
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 242
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 241
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 240
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 234
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 231
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 228
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 224
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 220
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 219
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 219
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 215
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 209
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 209
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 193
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 192
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 192
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 191
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 190
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 188
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 187
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 185
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 183
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 183
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 183
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 182
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 180
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 179
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 177
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 176
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 176
Effects of imidazoline I2 receptor ligands on acute nociception in rats 176
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 176
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 175
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 172
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 170
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 170
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 170
4WD to Travel Inside the 5-HT1A Receptor World 169
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 168
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 168
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 167
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 167
Adenosine receptors as promising targets for the management of ocular diseases 167
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 166
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 165
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 164
New insights in Au-NHCs complexes as anticancer agents 161
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 161
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 160
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 158
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 157
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 156
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 155
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 155
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 154
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 153
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 153
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 150
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 148
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 148
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 143
Trekking through receptor chemistry 140
Imidazoline nucleus as a biologically versatile scaffold 139
Effects of allyphenyline on chronic alcohol intoxication model 138
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 136
Efficient Lewis Acid Systems for the A3 Coupling reaction 136
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 134
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 133
null 132
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 131
null 129
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 128
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 127
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 126
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 126
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 124
Aminopyrimidines as inhibitors of the Wnt signalling pathway 123
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 121
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 121
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 119
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 118
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 115
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 114
Totale 20.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.662 0 0 0 0 0 171 345 112 213 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.150 241 112 427 246 194 266 606 1.176 437 325 335 785
2025/20264.801 492 575 1.603 1.191 806 134 0 0 0 0 0 0
Totale 24.546